Correlation Between BeiGene and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both BeiGene and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BeiGene and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BeiGene and Eliem Therapeutics, you can compare the effects of market volatilities on BeiGene and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BeiGene with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BeiGene and Eliem Therapeutics.
Diversification Opportunities for BeiGene and Eliem Therapeutics
-0.14 | Correlation Coefficient |
Good diversification
The 3 months correlation between BeiGene and Eliem is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding BeiGene and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and BeiGene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BeiGene are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of BeiGene i.e., BeiGene and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between BeiGene and Eliem Therapeutics
Given the investment horizon of 90 days BeiGene is expected to generate 0.42 times more return on investment than Eliem Therapeutics. However, BeiGene is 2.37 times less risky than Eliem Therapeutics. It trades about -0.29 of its potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of risk. If you would invest 21,722 in BeiGene on August 27, 2024 and sell it today you would lose (2,692) from holding BeiGene or give up 12.39% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.24% |
| Values | Daily Returns |
BeiGene vs. Eliem Therapeutics
Performance |
| Timeline |
| BeiGene |
| Eliem Therapeutics |
BeiGene and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BeiGene and Eliem Therapeutics
The main advantage of trading using opposite BeiGene and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BeiGene position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| BeiGene vs. Eliem Therapeutics | BeiGene vs. HCW Biologics | BeiGene vs. Scpharmaceuticals | BeiGene vs. Milestone Pharmaceuticals |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |